Trinity Biotech (TRIB)

P/S ratio as of November 2026 (TTM): 0.0753

According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0644. At the end of 2023 the company had a P/S ratio of 0.4571.

P/S ratio history for Trinity Biotech from 2001 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	0.4571	-21.44%
2022	0.5819	80.99%
2021	0.3215	-58.83%
2020	0.7809	226.95%
2019	0.2388	-51.58%
2018	0.4933	-54.18%
2017	1.08	-32.92%
2016	1.61	-42.93%
2015	2.81	-28.56%
2014	3.94	-38.56%
2013	6.41	63.51%
2012	3.92	41.29%
2011	2.77	33.09%
2010	2.08	210.58%
2009	0.6710	216.41%
2008	0.2121	-82.03%
2007	1.18	-12.04%
2006	1.34	6.54%
2005	1.26	144.61%
2004	0.5147	-47.16%
2003	0.9741	272%
2002	0.2619	-35.69%
2001	0.4072

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Abbott Laboratories ABT	4.22	5,502.48%	🇺🇸 USA
Thermo Fisher Scientific TMO	5.56	7,278.32%	🇺🇸 USA
Danaher DHR	6.33	8,301.21%	🇺🇸 USA
QuidelOrtho QDEL	0.2745	264.61%	🇺🇸 USA
OraSure Technologies OSUR	2.11	2,703.06%	🇺🇸 USA
Chembio Diagnostics CEMI	0.3457	359.11%	🇺🇸 USA
Bio-Rad Laboratories BIO	3.96	5,163.38%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Trinity Biotech (TRIB)

P/S ratio as of November 2026 (TTM): 0.0753